Check this link right here http://www.facebook.com/Cannabis-Science-Inc-Stock-1567596656901324 for more information on Cannabis science inc stock news. Cannabis Science alleviates suffering and promotes health through cannabinoid science. A pioneering biotech company, Cannabis Science creates cannabinoid-based extract formulations for various medical conditions. It can often be challenging just to find quotes to precisely price cannabis science Inc stock.

1. Cannabis
Science Inc
Stock News
Cannabis Science, Inc. takes advantage of its unique
understanding of metabolic processes to provide
innovative treatment options for unmet medical
needs.
Cannabis use has an extensive history dating back
thousands of years, and currently there are thousands
of peer-reviewed scientific publications that
document the underlying biochemical pathways that
cannabinoids modulate.

2. Cannabis Penny Stocks
Cannabis Science Inc Stock News
Cannabis Science Inc Stock
At Cannabis Science, we use an inquiring approach to discover and
develop novel cannabinoid-based therapies to improve patients’
lives. From the initiation, our founders have been committed to
fostering and maintaining a bold, pioneering spirit fostering the true
nature of innovation from which cutting edge ideas flourish and
translate into evidence-based solutions.

3. Cannabis Penny
Stocks
Cannabinoids have an extensive history dating back thousands of
years, and currently there are thousands of peer-reviewed scientific
publications that document the underlying biochemical pathways
that cannabinoids modulate. The endocannabinoid system
possessed by all vertebrates regulates all body systems and
maintains homeostasis. As such, the mechanisms of
phytocannabinoids’ biological impact are multidimensional.
Some applications of cannabinoids have been well established in
peer-reviewed literature such as alleviating nausea and stimulating
the appetite for people with AIDS and Cancer. Other well-known
uses include easing chronic pain and reducing muscle spasms
associated with neuromuscular disorders like MS and spinal cord
injuries. Some current uses are poorly understood, such as its
perceived effectiveness in alleviating certain autoimmune
disorders, such as Crohn’s Disease.
Our team of scientists will produce and commercialize products
derived from cannabis-based botanical extracts. Even today, new
uses for cannabinoids are consistently discovered. For example,
scientists recently found that topical cannabinoid-based
preparations can be effective against MRSI, the deadly antibiotic-
resistant flesh-eating disease. Other topical applications, which are
largely non-psychoactive, would target localized pain, such as
arthritis and burns, as well as neuropathic pain, for which there are
few effective treatments.

4. Cannabis Penny Stocks
In 2001, an article published in the Canadian Medical Association
Journal revealed that, based on self-identified needs, it is estimated
that 2% (or 400,000) of Canadian adults were already utilizing
cannabinoids for medical purposes. With ever increasing use and
scientific support for cannabinoid medicines occurring in the US
and around the world, we are looking at a new multi-billion dollar
industry that will play a dramatic role that will impact human health
on a global scale.
We are dedicated to working
closely with local, national and
international regulatory agencies to
provide access to high quality, first
class cannabinoid pharmaceuticals
to those critically in need of new
treatments for life threatening and
debilitating conditions. Cannabis
Science’s clinical trial material
comes from the cultivation and
production facilities that are cGMP
compliant, surpassing high quality
standard industrial and food
processing requirements.

5. Cannabis Science Inc Stock News
CBIS Sets the Stage for High-Growth Amidst DEA Historical
National Industry Changes for Critical Ailment Treatments &
Historic California Voting in November
LOS ANGELES, CA--(Marketwired - Jun 30, 2016) - Cannabis
Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in
the development of cannabis-based medicines, today announced the
relocation of their corporate headquarters to Irvine, California. The
company's HQ move to California will put them in closer proximity
to its vital laboratory resources, key distributors, and many patients.
This move will help the company cut costs, decrease time to market
for new products, and perform clinical trials more efficiently with a
new California laboratory, clinical trials unit, and medical treatment
facility to be announced shortly.
CBIS looks to target the high growth projected in the national
industry changes, such as the possible DEA reclassification of
cannabis which can positively multiply the efforts of the Company's
scientific team dramatically, and the Historic California voting in
November.
These changes can open the markets dramatically for the Company's
proprietary cannabinoid formulations being created to be distributed
nationwide. The urgent objective is the treatment of critical
ailments, such as, various Cancers, HIV/AIDS, Pain Management,
Autism, PTSD, and other neurological conditions. Though this list
represents only a handful of the targeted ailments we hope to treat, it
reflects some of the serious medical afflictions we are dealing with.

6. Cannabis Science Inc Stock
News
The Company fully understands that while the price is high, one
blockbuster pharmaceutical drug can change the framework forever
in Cannabis Science, and the Company believes it has more than one.
While the Company negotiates to close a new deal with its North
California property partners it continues forward with creating lab
expansions for IGXBio's GenePro FDA Investigational New Drug
(IND) Number 015982 for further drug development to identify &
develop agonist cannabinoids for GenePro, closing large educational
& cultivation property development deals utilizing the strengths of
Universities.
We feel empowered and strengthened with clinical drug development
confidence as GW Pharma announces positive results with its CBD-
Based Epilepsy formulation while mapping out its own critical
ailment drug development plans for many critical ailments based on
successful self-medicating cannabinoid cancer treatments and other
amplified results.

7. Cannabis Science Inc
Stock
The Company works with leading experts in
drug development, medicinal characterization,
and clinical research to develop, produce, and
commercialize novel therapeutic approaches
for the treatment of multiple critical ailments
from cancer and infections to age-related
illnesses and neurobehavioral disorders.

8. Cannabis
Science
Inc Stock
Cannabis Science is one of the longest standing companies
in the cannabis business.
We feel that the correct way is to look at the industry from
a bio-pharmaceutical standpoint, in a manner that allows
cannabinoid-based products to modulate the
endocannabinoid system to treat multiple conditions.
Scientifically, we know this is the beginning of one of the
greatest expansions of medicine and industry we will ever
experience in our lifetime.

9. Cannabis Science Inc Stock
Cannabis Science, Inc. is a patient oriented company
dedicated to meeting the needs of the community with
products based on cannabinoid science, as well as being an
advocate for patient rights throughout the world.
Cannabis Science, Inc., takes advantage of its unique understanding
of metabolic processes to provide novel treatment approaches to a
number of illnesses for which current treatments and understanding
remain unsatisfactory. Cannabinoids have an extensive history
dating back thousands of years, and currently, there are a growing
number of peer-reviewed scientific publications that document the
underlying biochemical pathways that cannabinoids modulate. The
Company works with leading experts in drug development,
medicinal characterization, and clinical research to develop,
produce, and commercialize novel therapeutic approaches for the
treatment for illnesses caused by infections as well as for age-
related illness. Our initial focus is on skin cancers, HIV/AIDS, and
neurological conditions. The Company is proceeding with the
research and development of its proprietary drugs as a part of this
initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1,
respectively.

10. www.cannabisscience.com
Cannabis Science Inc Stock News
For more information visit our website